Multicentre study to explore the correlation between smoking pattern and clinical efficacy of Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor (TKI) in male patients
Study identifier:NIS-OTW-IRE-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A multi-centre, naturalistic study to explore the correlation between smoking pattern and clinical efficacy of EGFR TKI in male patients with locally advanced or metastatic non-small cell lung cancer of adeno histology failed 1st line chemotherapy
Medical condition
Non Small Cell Lung Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Male
Actual Enrollment
186
Study type
Observational
Age
20 Years +
Date
Study Start Date: 01 Aug 2009
Primary Completion Date: 01 Dec 2010
Study Completion Date: 01 Dec 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Male patients with non-small cell lung cancer (NSCLC) of adeno histology | - |
Contacts
Investigators
Principal Investigator
Chun-Ming Tsai
Taipei Ventrans General Hospital
